Kneppers Chris J sold $10K of BIOF

Kneppers Chris J sold 100,000 shares of BLUE BIOFUELS, INC. (BIOF) at $0.10 on 2026-10-13.

Original reporting
SEC EDGAR · Kneppers Chris J
Published Oct 15, 2026, 6:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 6:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BIOF
Bearish
medium confidence
Mentioned
$BIOF
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BIOFBearishLow
01

Why it matters

Traders may briefly reassess sentiment around insider behavior, but the disclosed transaction size is small and unlikely to drive fundamentals by itself.

02

Market read

A director’s small open-market sale is disclosed via SEC EDGAR, which can influence short-term sentiment but is not a fundamental catalyst.

03

What to watch

No information is provided on total insider holdings changes beyond the post-transaction share count, nor on broader company catalysts or concurrent news.

Relevance 3/10Novelty 3/10Timing: today’s SEC Form 4 filing (filed Oct. 15) for an Oct. 13 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Blue Biofuels, Inc., reporting a director’s open-market sale.

Company-level read

Ticker impact

$BIOFBearishMedium confidence
Context

Blue Biofuels, Inc. director Chris J. Kneppers sold 100,000 shares in an open-market transaction at $0.1000/share, per Form 4 filed Oct. 15.

Expected impact

Likely mild downward pressure or increased volatility as traders weigh insider alignment versus routine diversification.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the dollar value ($10,000) is small and the article provides no 10b5-1 plan context (explicitly says none), limiting materiality.

Market effects

Minimal, as this is a single-company insider transaction with small disclosed value.

None indicated.

None indicated.

Counterpoint

The sale could be routine diversification or liquidity needs, and the absence of a 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • BIOF

    Blue Biofuels, Inc., the company whose director insider sale is disclosed.

  • Kneppers Chris J

    Director of BIOF who sold 100,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles